The preparation method of cabozantinib

A cabozantinib, reactive technology, applied in the field of preparation of the drug cabozantinib, can solve the problems of long route, low efficiency, unfavorable waste discharge control, etc., so as to improve reaction efficiency, facilitate industrial production, and reduce emissions Effect

Active Publication Date: 2022-05-13
江苏君若药业有限公司 +2
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] These methods all use 6,7-dimethoxy-4-hydroxyl-quinoline (formula II) as the key material, and the whole route is longer, which is unfavorable for the discharge control of waste, and is inefficient
At the same time, it involves dangerous reactions such as nitrification, high temperature, and chlorination of phosphorus oxychloride, which does not meet the needs of industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The preparation method of cabozantinib
  • The preparation method of cabozantinib
  • The preparation method of cabozantinib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Preparation of 6,7-dimethoxy-2-carboxy-quinoline (Formula VII)

[0023] Put 6-nitroveratraldehyde (63.4g, 0.3mol) and THF (380mL) into the 1000mL hydrogenation tank after nitrogen replacement, stir and dissolve, add 5% Pd / C (6.34g, water content 63.5%), nitrogen replacement Afterwards, the pressure of hydrogen gas was introduced to 0.1-0.2 MPa, and the temperature was kept at 25-30° C. for 4 hours. Vent to normal pressure, and filter to remove the catalyst. Transfer the filtrate to a 1000mL four-neck flask, add ethyl pyruvate (38.3g, 0.33mol), raise the temperature to 60°C, add sodium ethoxide solid (30.6g, 0.45mol) in portions, after the addition, keep the reaction at 60-65°C After 4 hours, additional water (200 mL) was added, and the reaction was continued at 60-65° C. for 2 hours. After cooling down, most of the THF was removed by rotary evaporation. The residue was added with water (300mL) and tertiary methyl ether (200mL) to extract the layers. The aqueous layer ...

Embodiment 2

[0025] Preparation of 6,7-dimethoxy-2-carboxy-quinoline (Formula VII)

[0026] 500mL four-necked bottle, put in water (100mL), ethanol (100mL), potassium formate (42.1g, 0.5mol) and formic acid (27.6g, 0.6mol) after nitrogen replacement, add 6-nitroveratraldehyde ( 21.1 g, 0.1 mol), after nitrogen was fully replaced, 5% Pd / C (3.15 g, moisture content 63.5%) was added, and the temperature was slowly raised to 60° C. for 6 h until almost no gas was released. Add methyl pyruvate (11.23g, 0.1mol), raise the temperature to 80-85°C and stir for 30min, then slowly add sodium hydroxide solution (22gNaOH, 100mL water) dropwise, and continue to react at 80-85°C for 2 hours after the dropwise addition. After cooling down, the catalyst was removed by filtration, and the pH value of the filtrate was adjusted to 6-7 with 10% hydrochloric acid, and a large amount of solids were precipitated. Filter, rinse the filter cake with water (50 mL) and suction filter, and air-dry the filter cake at ...

Embodiment 3

[0028] Preparation of 6,7-dimethoxy-2-carboxy-4-chloro-quinoline (formula VIII)

[0029] Add SOCl to 500mL four-necked bottle 2 (150mL), slowly add DMF (3mL) under stirring, then add 6,7-dimethoxy-2-carboxy-quinoline solid (formula VII, 46.6g, 0.2mol), slowly heat up to 75-80°C for reaction After 18 hours, acid gas was released. After cooling down, add toluene (200mL) to dilute the reactant, concentrate under reduced pressure until it is difficult to stir, add toluene (100mL) again and concentrate under reduced pressure until it becomes difficult to stir, add toluene (100mL) to the residue to disperse the solid, cool to 5°C, drop Water (10 mL) was added and the resulting solid-liquid mixture was stirred for 1 hour. Filter, put the filter cake into sodium acetate aqueous solution (sodium acetate 24.6g, water 300mL) for beating and washing for 2 hours, filter, rinse the filter cake fully with water (150mL) and then filter, blow dry the filter cake at 55°C overnight to obtain 6...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The object of the present invention is to provide a more efficient method for synthesizing cabozantinib, which uses 6-nitroveratraldehyde as a starting material, and completes reduction, cyclization, and hydrolysis reactions in one pot to obtain 6,7- Dimethoxy-2-carboxy-quinoline, then treated with thionyl chloride to obtain 6,7-dimethoxy-2-carboxy-4-chloro-quinoline, and finally again under copper catalyst system conditions The kettle method completes the condensation and decarboxylation reactions to obtain the target product cabozantinib.

Description

technical field [0001] The invention relates to the technical field of preparation methods of raw materials, in particular to the preparation of drug cabozantinib. Background technique [0002] Cabozantinib, developed by Exelixis Biopharmaceutical Company of the United States, is a multi-target small molecule tyrosine kinase inhibitor that was approved by the FDA in 2012. Compared with other targeted drugs, cabozantinib targets more targets, mainly including MET, VEGFR1 / 2 / 3, ROS1, RET, AXL, NTRK, KIT, etc. Therefore, cabozantinib is a broad-spectrum anticancer drug that has applications in a variety of solid tumors, such as liver cancer, soft tissue sarcoma, non- Small cell lung cancer, prostate cancer, breast cancer, ovarian cancer, bowel cancer, etc. [0003] The chemical name of cabozantinib (formula I) is N-4[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(4-fluorophenyl )-1,1-cyclopropanedicarboxamide. The compound does not contain a chiral center, and its structure co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D215/22
CPCC07D215/22
Inventor 魏万国徐梓宸方显杰朱信磊刘汝丰裔明月周成龙
Owner 江苏君若药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap